Table 1.
Subgroup analysis of PTPL1 expression and overall survival time of lung cancer patients.
| Patient number | HR | P | ||
|---|---|---|---|---|
| High expression | Low expression | |||
| Histology type | ||||
| NSCLC | 963 | 963 | 0.74(0.65–0.84) | <0.05 |
| Adenocarcima | 358 | 362 | 0.49(0.39–0.63) | <0.05 |
| Squamous | 262 | 262 | 1(0.79–1.27) | 0.99 |
| Gender | ||||
| Male | 549 | 551 | 0.81(0.69–0.95) | <0.05 |
| Female | 357 | 358 | 0.65(0.52–0.82) | <0.05 |
| Smoking | ||||
| Smoking/Ever | 249 | 250 | 0.77(0.59–1.01) | 0.054 |
| Never smoking | 103 | 102 | 0.35(0.19–0.65) | <0.05 |
| Stage | ||||
| Stage 1 | 185 | 185 | 0.4(0.26–0.6) | <0.05 |
| Stage 2 | 68 | 68 | 0.48(0.29–0.78) | <0.05 |
| Stage 3 | 12 | 12 | 0.27(0.09–0.83) | <0.05 |